Przejdź do zawartości
Merck
Wszystkie zdjęcia(1)

Kluczowe dokumenty

Wyświetl całą dokumentację

1359415

USP

Levetiracetam Racemic Mixture

United States Pharmacopeia (USP) Reference Standard

Synonim(y):

(RS)-α-Ethyl-2-oxo-1-pyrrolidineacetamide, 2(RS)-(2-Oxopyrrolidin-1-yl)butyramide, Etiracetam

Zaloguj sięWyświetlanie cen organizacyjnych i kontraktowych
Wszystkie zdjęcia(1)

About This Item

Wzór empiryczny (zapis Hilla):
C8H14N2O2
Numer CAS:
33996-58-6
Masa cząsteczkowa:
170.21
Beilstein:
1529106
Numer MDL:
MFCD00868507
Kod UNSPSC:
41116107
Identyfikator substancji w PubChem:
329750034
NACRES:
NA.24

klasa czystości

pharmaceutical primary standard

rodzina API

levetiracetam

producent / nazwa handlowa

USP

Zastosowanie

pharmaceutical (small molecule)

Format

neat

ciąg SMILES

CCC(N1CCCC1=O)C(N)=O

InChI

1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)

Klucz InChI

HPHUVLMMVZITSG-UHFFFAOYSA-N

Opis ogólny

Levetiracetam racemic mixture also know as etiracetam is an stuctural analogue ethylated piracetam drug.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Zastosowanie

Levetiracetam Racemic Mixture USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monograph such as Levetiracetam

Komentarz do analizy

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Inne uwagi

Sales restrictions may apply.
Ta strona może zawierać tekst przetłumaczony maszynowo.

produkt powiązany

Numer produktu
Opis
Cennik

1359404

Levetiracetam, United States Pharmacopeia (USP) Reference Standard

1359437

Levetiracetam Related Compound B, United States Pharmacopeia (USP) Reference Standard

1359426

Levetiracetam Related Compound A, United States Pharmacopeia (USP) Reference Standard

Y0001253

Levetiracetam, European Pharmacopoeia (EP) Reference Standard

Y0001256

Levetiracetam impurity C, European Pharmacopoeia (EP) Reference Standard

Y0001254

Levetiracetam impurity A, European Pharmacopoeia (EP) Reference Standard

Y0001257

Levetiracetam impurity D, European Pharmacopoeia (EP) Reference Standard

Y0000659

Pyrrolidone, European Pharmacopoeia (EP) Reference Standard

PHR1447

Levetiracetam, Pharmaceutical Secondary Standard; Certified Reference Material

Y0001962

Levetiracetam impurity E, European Pharmacopoeia (EP) Reference Standard

Y0001948

Levetiracetam impurity G, European Pharmacopoeia (EP) Reference Standard

PHR2432

Levetiracetam Related Compound B, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2428

Levetiracetam Related Compound A, Pharmaceutical Secondary Standard; Certified Reference Material

Piktogramy

Exclamation markEnvironment
GHS07,GHS09

Hasło ostrzegawcze

Warning

Zwroty wskazujące rodzaj zagrożenia

H302,H319,H411

Klasyfikacja zagrożeń

Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Irrit. 2

Kod klasy składowania

11 - Combustible Solids

Klasa zagrożenia wodnego (WGK)

WGK 2

Temperatura zapłonu (°F)

Not applicable

Temperatura zapłonu (°C)

Not applicable

Wybierz jedną z najnowszych wersji:

Certyfikaty analizy (CoA)

Lot/Batch Number

Przepraszamy, ale COA dla tego produktu nie jest aktualnie dostępny online.

Proszę o kontakt, jeśli potrzebna jest pomoc Obsługa Klienta

Masz już ten produkt?

Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.

Odwiedź Bibliotekę dokumentów

Klienci oglądali również te produkty

Slide 1 of 6

1 of 6

Tiagabine hydrochloride ≥98% (HPLC)

Sigma-Aldrich

SML0035

Tiagabine hydrochloride

Levetiracetam Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1447

Levetiracetam

Levetiracetam impurity C European Pharmacopoeia (EP) Reference Standard

Y0001256

Levetiracetam impurity C

Levetiracetam solution 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Supelco

L-020

Levetiracetam solution

Piracetam European Pharmacopoeia (EP) Reference Standard

Y0000288

Piracetam

(S)-(+)-2-Aminobutanamide hydrochloride 97%

Sigma-Aldrich

679399

(S)-(+)-2-Aminobutanamide hydrochloride

Can zinc depletion play a role in LEV-induced hair loss? Considerations from a case study.
Rocco Salvatore Calabrò et al.
Epilepsy & behavior : E&B, 29(1), 254-255 (2013-08-14)
Adrian Budhram et al.
Archives of physical medicine and rehabilitation, 95(3), 588-590 (2013-09-26)
Postanoxic myoclonus is a rare manifestation after an anoxic event, with fewer than 150 cases reported in the literature. The condition is characterized by myoclonic jerks, which are worse on action than at rest, and postural lapses, ataxia, and dysarthria.
S J Sara
Psychopharmacology, 68(3), 235-241 (1980-01-01)
Etiracetam, a nonanaleptic drug related to the nootropic substance piracetam, was found to facilitate memory retrieval in rats in several experimental situations, when injected 30 min prior to retention testing. The drug was active when memory deficits were induced by
Aaron M Cook et al.
Neurocritical care, 19(2), 210-214 (2013-08-03)
Increased creatinine clearance and subsequent elevated antimicrobial clearance is evident in many traumatic brain injury (TBI) patients due to augmented renal clearance (ARC). Little is known about the effects of ARC on other renally-eliminated medications, such as the anti-epileptic drug
Vincenzo Belcastro et al.
Epileptic disorders : international epilepsy journal with videotape, 15(4), 440-443 (2013-10-31)
Early-onset absence epilepsy refers to patients with absence seizures beginning before age 4 and comprises a heterogeneous group of epilepsies. Onset of absence seizures in the first year of life is very rare. We report a boy with absence seizures
Wyświetl wszystkie powiązane dokumenty

Nasz zespół naukowców ma doświadczenie we wszystkich obszarach badań, w tym w naukach przyrodniczych, materiałoznawstwie, syntezie chemicznej, chromatografii, analityce i wielu innych dziedzinach.

Skontaktuj się z zespołem ds. pomocy technicznej